SBIR/STTR Research Award

FLOW MONITOR FOR CENTRAL NERVOUS SYSTEM SHUNTS

Award identifier 6a6edd105dabf96063f77e7e5aca5039c70d807a0e44719e442098ccd7968ba5Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$140,000

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
EUNOE, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Cerebrospinal fluid (CSF) shunting is the principal treatment available for hydrocephalus. Although treatment efficacy is completely dependent on CSF flow through the device, current shunts do not provide any noninvasive means for monitoring the flow of CSF. To address this void in shunt technology, Eunoe is developing an implantable CSF shunt monitor that is designed to measure the rate of CSF flow noninvasively through implanted shunts. Currently, there are approximately 100,000 CSF shunts implanted or replaced annually worldwide. CSF shunts consist of an inflow catheter, most often positioned in a lateral ventricle, connected to a valve, and attached to an outflow catheter that drains into a lower body cavity, most often the abdomen. Shunts, which have a fifty-year history of use in hydrocephalus, are prone to dysfunction. In pediatric series, shunt failure ranges from 25 percent to 40 percent within twelve months of surgery, with a 4-5 percent risk for each year thereafter. Mechanical or functional failure, with inadequate CSF flow, account for the vast majority of complications. Invasive methods for assessing CSF flow through a shunt, "shuntograms," are costly, time consuming, and place the patient at risk of central nervous system infection. Shunt failure is most often detected by return or worsening of neurologic symptoms. In hydrocephalus, undetected shunt dysfunction can lead to permanent neurological damage or death. The Eunoeflow monitoring device is being designed to monitor flow both in existing CSF shunts and for incorporation into new shunt implants. This Phase 1 R&D plan focuses on development of the breadboard phase of the Eunoeflow sensor. This phase of the development cycle will be completed when a breadboard is successfully tested and found to meet the performance specifications. It therefore incorporates the design, fabrication, and validation of all test systems necessary to validate this performance. The performance specifications are a subset of the operational engineering specifications related to device performance, exclusive of issues associated with size, or materials.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.